Skip to main content

Implementing Biomedical HIV Prevention Advances in Uganda

  • Chapter
  • First Online:
Biomedical Advances in HIV Prevention

Abstract

Uganda’s rising HIV epidemic is a cause of concern. HIV prevalence has increased from 6.4 to 7.3 % in a space of 6 years (2005–2011), and the number of new HIV infections in adults and children is estimated to have increased from 130,000 in 2010 to 145,000 in 2011 based on results from mathematical models. In order to reverse this trend, Uganda has adopted a national combination HIV prevention approach that involves implementation of biomedical, behavioral, and structural interventions at a scale, quality, and intensity necessary to impact the epidemic. This chapter discusses Uganda’s progress in implementing biomedical HIV prevention interventions, including HIV counseling and testing (HCT), voluntary medical male circumcision (VMMC), antiretroviral therapy (ART), and prevention of mother-to-child transmission (PMTCT) of HIV. Modeling studies suggest that the coverage of these interventions should reach 80–90 % of the adult population if Uganda is to reverse the current epidemic trends by 2015. Reports from the Ugandan Ministry of Health suggest that the coverage of HCT, PMTCT and ART services has increased over the past 5 years. For instance, the percentage of health facilities (HFs) offering HCT has increased from 37 % in 2009/10 to 38 % in 2011/12. The percentage of HFs offering PMTCT services has also increased from 23 % in 2009/10 to 36% in 2011/12. By the end of 2012, approx. 24 % of 4,493 HFs in Uganda were actively offering ART. Despite this level of coverage, only 26 % of Ugandan men are circumcised, 73 % of eligible HIV-positive patients receive antiretrovirals (ARVs), 87.4 % of all HIV-positive pregnant women identified at antenatal clinics, during labor and delivery, and during the post-natal period receive prophylactic ART to reduce the risk of mother-to-child transmission of HIV (constituting approx. 52 % of all expected HIV-positive pregnant women in Uganda), while 34 % of women and 55 % of men are not aware of their HIV status. Several challenges still inhibit national scale-up of these interventions, including the slow progress in translation of research into policy, lack of adequate resources to put everybody who is eligible for ART on treatment, and the fact that the majority of Ugandans present late for HIV diagnosis, and therefore enter late (with lower CD4 cell counts) into HIV care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Government health facilities are graded into Health Centers and Hospitals, depending on the population and geographical areas served. The lowest level facility is Health Center I (HC I) which serves the village level, approximately 1,000 people. From HC I, the assignment of levels increases in grade as the population and geographical areas served increase—from HC II (which serves a parish, approximately 5,000 people) through HC III (which serves a subcounty, approximately 20,000 people) and HC IV (which serves a county, approximately 100,000 people) to a District Hospital (district level, approximately 500,000 people), Regional Referral Hospital (which serves approximately 3 million people or 3-5 districts), and National Referral Hospital, which serves approximately 10 million people.

  2. 2.

    HCT was provided as a service to study participants. Therefore, HCT services were available to community residents who had participated in research and who had provided a blood sample. Approximately 15,000 adults (15–49 years) were followed up through annual HIV surveillance surveys conducted in 50 communities in Rakai district.

References

  1. Serwadda D, Mugerwa RD, Sewankambo NK, Lwegaba A, et al. Slim disease: a new disease in Uganda and its association with HTLV-III Infection. Lancet. 1985;326(8460):849–52.

    Article  Google Scholar 

  2. Slutkin G, Okware S, Naamara W, Sutherland D, Flanagan D, et al. How Uganda reversed its HIV epidemic. AIDS Behav. 2006;10(4):351–60.

    Article  PubMed  Google Scholar 

  3. Green EC, Halperin DT, Nantulya V, Hogle JA. Uganda’s HIV prevention success: the role of sexual behavior change and the national response. AIDS Behav. 2006;10(4):335–46.

    Article  PubMed  Google Scholar 

  4. Asiimwe-Okiror G, Opio AA, Musinguzi J, Madraa E, Tembo G, Carael M. Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda. AIDS. 1997;11(14):1757–63.

    Article  PubMed  CAS  Google Scholar 

  5. Kirungi WL, Musinguzi J, Madraa E, Mulumba N, Callejja T, Ghys P, Bessinger R. Trends in antenatal HIV prevalence in urban Uganda associated with uptake of preventive sexual behaviour. Sex Transm Infect. 2006 Apr;82:Suppl 1:i36–41.

    Article  PubMed  Google Scholar 

  6. Uganda Bureau of Statistics (UBOS) and ICF International Inc. Uganda AIDS Indicator Survey 2011. Kampala, Uganda/Calverton, Maryland: UBOS/ICF International Inc; 2012.

    Google Scholar 

  7. Kasamba I, Baisley K, Mayanja BN, Maher D, Grosskurth G. The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999–2009. Trop Med Int Health. 2012;17(8):e66–73.

    Article  PubMed  Google Scholar 

  8. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155:209–16.

    Article  PubMed  Google Scholar 

  9. Ministry of Health and ORC Macro. Uganda HIV/AIDS Sero-behavioural Survey. Calverton, Maryland, USA: Ministry of Health/ORC Macro; 2006.

    Google Scholar 

  10. Wabwire-Mangen F, Odiit M, Kirungi W, Kaweesa Kisitu D. Modes of transmission study, analysis of HIV prevention response and modes of HIV transmission: the Uganda country synthesis report. Kampala, Uganda: GoU/UNAIDS/UAC; 2009.

    Google Scholar 

  11. UNAIDS. Knowledge is power: voluntary HIV counselling and testing in Uganda. Geneva: UNAIDS; June 1999.

    Google Scholar 

  12. Matovu JK, Gray RH, Makumbi F, Wawer MJ, et al. Voluntary HIV counseling and testing acceptance, sexual risk behavior and HIV incidence in Rakai, Uganda. AIDS. 2005;19:503–11.

    Article  PubMed  Google Scholar 

  13. Were W, Mermin J, Bunnell R, Ekwaru JP, Kaharuza F. Home-based model for HIV voluntary counselling and testing. Lancet. 2003;361(9368):1569.

    Article  PubMed  Google Scholar 

  14. Wolff B, Nyanzi B, Katongole G, Ssesanga D, Ruberantwari A, Whitworth J. Evaluation of a home-based voluntary counselling and testing intervention in rural Uganda. Health Policy Plann. 2005;20(2):109–16.

    Article  Google Scholar 

  15. Tumwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F. High uptake of home-based, district-wide, HIV counseling and testing in Uganda. AIDS Patient Care STDS. 2010;24(11):735–41.

    Article  PubMed  Google Scholar 

  16. Sekandi JN, Sempeera H, List J, Mugerwa MA, Asiimwe S, Yin X, Whalen CC. High acceptance of home-based HIV counseling and testing in an urban community setting in Uganda. BMC Public Health. 2011;11:730.

    Article  PubMed  Google Scholar 

  17. Nuwaha F, Kasasa S, Wana G, Muganzi E, Tumwesigye E. Effect of home-based HIV counselling and testing on stigma and risky sexual behaviours: serial cross-sectional studies in Uganda. J Int AIDS Soc. 2012;15(2):17423.

    Article  PubMed  Google Scholar 

  18. Matovu JK, Kigozi G, Nalugoda F, Wabwire-Mangen F, Gray RH. The Rakai project counseling program experience. Trop Med Int Health. 2002;7(12):1064–67.

    Article  PubMed  Google Scholar 

  19. Lugada E, Levin J, Abang B, Mermin J, Mugalanzi E, Namara G, Gupta S, Grosskurth H, Jaffar S, Coutinho A, et al. Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr. 2010;55(2):245–52.

    Article  PubMed  Google Scholar 

  20. UNAIDS. National AIDS programmes: a guide to monitoring and evaluation. Geneva: UNAIDS (UNAIDS/00.17E); 2000.

    Google Scholar 

  21. Were WA, Mermin JH, Wamai N, Awor AC, Bechange S, Moss S, Solberg P, Downing RG, Coutinho A, Bunnell RE. Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr. 2006;43(1):91–5.

    Article  PubMed  Google Scholar 

  22. Wanyenze R, Kamya M, Liechty CA, Ronald A, Guzman DJ, Wabwire-Mangen F, Mayanja-Kizza H, Bangsberg DR. HIV counseling and testing practices at an urban hospital in Kampala, Uganda. AIDS Behav. 2006;10(4):361–7.

    Article  PubMed  Google Scholar 

  23. Wanyenze RK, Nawavvu C, Namale AS, Mayanja B, Bunnell R, Abang B, et al. Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals. Bull World Health Organ. 2008;86:302–9.

    Article  PubMed  Google Scholar 

  24. Nakanjako D, Kamya M, Daniel K, Mayanja-Kizza H, Freers J, Whalen C, et al. Acceptance of routine testing for HIV among adult patients at the medical emergency unit at a national referral hospital in Kampala, Uganda. AIDS Behav. 2007;11:753–58.

    Article  PubMed  Google Scholar 

  25. Baggeley R, Hensen B, Ajose O, Grabbe KL, et al. From caution to urgency: the evolution of HIV testing and counseling in Africa. Bull World Health Organ. 2012;90:652–8B.

    Article  Google Scholar 

  26. Allen S, Tice J, Van de Perre P, Serufilira A, Hudes E, Nsengumuremyi F, et al. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ. 1992;304(6842):1605–09.

    Article  PubMed  CAS  Google Scholar 

  27. Dunkle KL, Stephenson R, Karita E, Kayitenkore K, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet. 2008;371:2183–91.

    Article  PubMed  Google Scholar 

  28. Ministry of Health (MoH). National couplesʼ HIV counseling and 2 communication strategy. Kampala: MoH; 2009.

    Google Scholar 

  29. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med. 2005;2(11):e298.

    Article  PubMed  Google Scholar 

  30. Gray RH, Kigozi G, Serwadda D, Makumbi F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–66.

    Article  PubMed  Google Scholar 

  31. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet. 2007;369:643–56.

    Article  PubMed  Google Scholar 

  32. Reed JB, Njeuhmeli E, Thomas AG, Bacon MC, et al Voluntary medical male circumcision: an HIV prevention priority for PEPFAR. J Acquir Immune Defic Syndr. 2012;60(Suppl. 3):S88–S95.

    Article  PubMed  Google Scholar 

  33. Ocero AA, Kisembo G, Ciccio L, Fullem A, Beal K. Scaling-up medical male circumcision for HIV prevention in a non-circumcising community. XIX International AIDS Conference, Washington, D.C. July 22–27, 2012. Abstract#: WEPE242.

    Google Scholar 

  34. Ndifuna M, Kironde S, Tibenderana E, Serumaga Mulema V, Mutesasira K. Moving from tens to thousands: how using multiple approaches in East Central Uganda is rapidly scaling-up voluntary medical male circumcision in traditionally non-circumcising areas. XIX International AIDS Conference, Washington, D.C. July 22–27, 2012. Abstract#: WEPE241.

    Google Scholar 

  35. Buwembo DR, Musoke R, Kigozi G, Ssempijja V, Serwadda D, Makumbi F, et al. Evaluation of the safety and efficiency of the dorsal slit and sleeve methods of male circumcision provided by physicians and clinical officers in Rakai, Uganda. BJU Int. 2012;109(1):104–8.

    Article  PubMed  Google Scholar 

  36. Kigozi G, Musoke R, Watya S, Kighoma N, et al. The acceptability and safety of the Shang Ring for adult male circumcision in Rakai, Uganda. J Acquir Immune Defic Syndr. 2013 Apr 22 [Epub ahead of print].

    Google Scholar 

  37. Gray R, Kigozi G, Kong X, Ssempijja V, Makumbi F, Watya S, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a post-trial follow-up study. AIDS. 2012;26(5):609–15.

    Article  PubMed  Google Scholar 

  38. Wawer MJ, Kigozi G, Serwadda D, et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomized controlled trial. Lancet. 2009;374:229–37.

    Article  PubMed  Google Scholar 

  39. Baeten JM, Donnell D, Kapiga SH, et al. Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1 serodiscordant couples. AIDS. 2010;24(5):737–44.

    Article  PubMed  Google Scholar 

  40. Weiss HA, Hankins CA, Dickson K. Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9(11):669–77.

    Article  PubMed  Google Scholar 

  41. Wawer MJ, Tobian AA, Kigozi G, Kong X, Gravitt PE, Serwadda D, Nalugoda F, Makumbi F, et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet. 2011;377(9761):209–18.

    Article  PubMed  Google Scholar 

  42. Katabira E, Kamya M (edtors). National antiretroviral treatment and care guidelines for adults and children. Kampala, Uganda: Ministry of Health; 2003.

    Google Scholar 

  43. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354(9181):795–802.

    Article  PubMed  CAS  Google Scholar 

  44. WHO. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: WHO; 2012.

    Google Scholar 

  45. Commission UAIDS. Mid-term evaluation of the National HIV and AIDS Strategic Plan (2007/08–2011/12). Kampala: Uganda AIDS Commission; 2011.

    Google Scholar 

  46. Albert LM, Akol A, L’Engle K, Tolley EE, et al. Acceptability of male circumcision for prevention of HIV infection among men and women in Uganda. AIDS Care. 2011;23(12):1578–85.

    Article  PubMed  Google Scholar 

  47. Ministry of Health. Integrated national guidelines on antiretroviral therapy, prevention of mother to child transmission of HIV and infant & child feeding. Kampala, Uganda: Ministry of Health; 2011.

    Google Scholar 

  48. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52(2):280–89.

    Article  PubMed  Google Scholar 

  49. Wanyenze RK, Kamya MR, Fatch R, Mayanja-Kizza H, Baveewo S, Sawires S, et al. Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. PLoS One. 2011;6:e21794.

    Google Scholar 

  50. Jain V, Byonanebye D, Muhaawe J, Kabami J, Black D, et al. Patient attitudes toward initiating early antiretroviral therapy at high CD4+ cell counts above national guideline thresholds. XIX International AIDS Conference, Washington, D.C. July 22–27, 2012. Abstract#: TUPE081.

    Google Scholar 

  51. Wanyenze RK, Tumwesigye NM, Kindyomunda R, Beyeza-Kashesya J, Atuyambe L, et al. Uptake of family planning methods and unplanned pregnancies among HIV-infected individuals: a cross-sectional study among clients at HIV clinics in Uganda. J Int AIDS Soc. 2011;14:35.

    Article  PubMed  Google Scholar 

  52. Cohen MS, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, et al. HPTN 052 study team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.

    Article  PubMed  CAS  Google Scholar 

  53. Matsiko D. The Uganda country case study: enhancing health worker and health system performance. The Global Health Workforce Alliance; 2010.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph KB Matovu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Matovu, J., McGrath, N. (2014). Implementing Biomedical HIV Prevention Advances in Uganda. In: Eaton, L., Kalichman, S. (eds) Biomedical Advances in HIV Prevention. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8845-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8845-3_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8844-6

  • Online ISBN: 978-1-4614-8845-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics